Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lacosamide Replacement for Oral in Partial Seizures
NCT00151879Phase 3Completed
- Sponsor
- UCB
- Start
- Feb 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in focal seizures, sponsored by UCB. Primary endpoint: Adverse Events. Started Feb 2005; status: completed.
02
Drugs
lacosamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00151879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151879.